Clinical Trial: A Phase II Trial of Cetuximab and Bevacizumab in Patients With Recurrent or Metastatic Head and Neck Cancer
Sponsor and Collaborators
University of Pittsburgh
National Cancer Institute (NCI)
Contact: Athanassios Argiris, MD
Contact: Rita Johnson, RN
Athanassios Argiris, MD ECOG
Next post in Head and Neck Cancer Clinical Trials
Log in to continue reading this article.
Don’t miss out on today’s top content on Oncology Nurse Advisor. Register for free and gain unlimited access to:
- Clinical Updates
- Evidence-Based Guidance
- Conference Coverage
- Full-Length Features
- Drug Monographs
- And More
Want to read more?
Please login or register first to view this content.